| (Values in U.S. Thousands) | Dec, 2012 | Dec, 2011 | Dec, 2010 | Dec, 2009 | Dec, 2008 |
| Sales | 540 | 260 | 440 | 1,530 | 41,230 |
| Sales Growth | +107.69% | -40.91% | -71.24% | -96.29% | -6.30% |
| Net Income | -11,650 | -8,110 | -19,990 | -9,150 | -50,410 |
| Net Income Growth | -43.65% | +59.43% | -118.47% | +81.85% | -10.89% |
Catasys Inc (CATSD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Catasys, Inc. is a healthcare services company, providing specialized health services designed to assist health plans, employers and unions to manage and treat their high cost substance dependence members through a network of healthcare providers and its employees. The OnTrak substance dependence program was designed to address substance dependence as a chronic disease. The program seeks to improve member health through the delivery of integrated medical and psychosocial interventions in combination with long term 'care coaching' thereby lowering overall healthcare costs. The Company also offers the PROMETA Treatment Program for alcoholism and stimulant dependence on a private-pay basis through licensed treatment providers and a company managed treatment center that offers the PROMETA Treatment Program, as well as other treatments for substance dependencies.